Skip to main content
Log in

p-chloroamphetamine- and d-fenfluramine-induced brain serotonin release in experimental portal-systemic encephalopathy

  • Original Contributions
  • Published:
Metabolic Brain Disease Aims and scope Submit manuscript

Abstract

Portal-systemic encephalopathy (PSE) is associated with increased brain turnover of serotonin (5-HT)in vivo but the brain 5-HT output seems to be unaltered. Recent results suggest, however, that an augmented neocortical 5-HT release in experimental chronic PSE may prevail under certain conditions. In the present study, neocortical extracellular 5-HT and 5-hydroxyindoleacetic-3-acid (5-HIAA) levels were measured in portacaval shunted (PCS) rats and sham-operated controls following local administration of p-chloroamphetamine (pCA) and d-fenfluramine (dFEN), two specific 5-HT releasing agents. The basal neocortical extracellular 5-HT concentrations were unaltered and the 5-HIAA levels were elevated in experimental PSE, supporting an unchanged brain 5-HT output despite elevated brain 5-HT metabolism. Perfusion with pCA or dFEN (5 μM; one 20-min pulse) produced marked increases in brain 5-HT release both in PCS and sham-operated rats compared with corresponding basal values. While no difference in the 5-HT response to dFEN administration was seen between sham (5-HT levels increased by 330%) and PCS (500%) rats, a clear difference (P<0.05) in the brain 5-HT output was observed between the two experimental groups following pCA perfusion (sham, 1100% versus PCS, 1470%). These results support our previous contention of an enhanced neocortical 5-HT output in experimental chronic PSE under certain pharmacological conditions.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Adell, A., Sarna, G.S., Hutson, P.H., and Curzon, G. (1989). Anin vivo dialysis and behavioural study of the release of 5-HT by p-chloroamphetamine in reserpine-treated rats.Br. J. Pharmacol. 97:206–212.

    PubMed  CAS  Google Scholar 

  • Bengtsson, F., Bugge, M., Brun, A., Falck, B., Henriksson, K.G., and and Nobin, A. (1988). The impact of time after portacaval shunt in the rat on behavior, brain serotonin, and brain and muscle histology.J. Neurolog. Sci. 83:109–122.

    Article  CAS  Google Scholar 

  • Bengtsson, F., Bugge, M., and Nobin, A. (1989). Hepatocerebral dysfunction and brain serotonin. In (R. F. Butterworth, and G. Pomier Layrargues, eds.)Hepatic Encephalopathy: Pathophysiology and Treatment. Humana Press, Clifton, NJ, pp. 355–387.

    Google Scholar 

  • Bengtsson, F. (1992). Neurotransmission failure in hepatic encephalopathy involving the combined action of different brain tryptophan-related pathology: a speculative synthesis. In (I. Ishiguro, T. Nagatsu, and Y. Nagamura, eds.),Advances in Tryptophan Research 1992. Fujita Health University Press, Toyoake, Japan, pp. 303–308.

    Google Scholar 

  • Bengtsson, F., and Bergqvist, P.B.F. (1996). Neuropsychiatric implications of brain tryptophan: Perturbations appearing in hepatic encephalopathy. In (G.A. Filippini, C.V.L. Costa, and A. Bertazzo, eds.).Recent Advances in Tryptophan Research. Plenum, New York, NY, pp. 387–395.

    Google Scholar 

  • Bergqvist, P.B.F., Vogels, B.A.P.M., Bosman, D.K., Maas, M.A.W., Hjorth, S., Chamuleau, R.A.F.M., and Bengtsson, F. (1995). Neocortical dialysate monoamines of rats after acute, subacute, and chronic liver shunt.J. Neurochem. 64:1238–1244.

    Article  PubMed  CAS  Google Scholar 

  • Bergqvist, P.B.F., Hjorth, S., Apelqvist, G., and Bengtsson, F. (1996a). Acute effects of L-tryptophan on brain extracellular 5-HT and 5-HIAA levels in chronic experimental portal-systemic encephalopathy.Metab. Brain Dis. 11:269–278.

    Article  PubMed  CAS  Google Scholar 

  • Bergqvist, P.B.F., Hjorth, S., Audet, R., Apelqvist, G., Bengtsson, F., and Butterworth R.F. (1996b). Ammonium acetate challenge in experimental hepatic encephalopathy induces a transient increase of brain 5-HT releasein vivo.Eur. Neuropsychopharmacology 6:317–324.

    Article  Google Scholar 

  • Bergqvist, P.B.F., Hjorth, S., Apelqvist, G., and Bengtsson, F. (1997). Potassium-evoked neuronal release of serotonin in experimental chronic portal-systemic encephalopathy.Metab. Brain Dis. 12:185–194.

    Google Scholar 

  • Bergqvist, P.B.F., and Bengtsson, F. (1997). Brain tryptopha-related perturbations in hepatic encephalopathy: an update. In (R. Richard, ed.).Current Topics in Neurochemistry, Research Trends, Trivandrum, India. In press.

    Google Scholar 

  • Bonanno, G., Fassio, A., Severi, P., Ruelle, A., and Raiteri, M. (1994). Fenfluramine releases serotonin from human brain nerve endings by a dual mechanism.J. Neurochem. 63: 1163–1166

    Article  PubMed  CAS  Google Scholar 

  • de Parada, M.P., Parada, M.A., Pothos, E., and Hoebel B.G. (1995). d-Fenfluramine, but not d-norfenfluramine, uses calcium to increase extracellular serotonin.Life Sci. 56:415–420.

    Google Scholar 

  • Fuller, R.W., Hines, C.W., and Mills, J. (1965). Lowering of brain serotonin level by chloroamphetamines.Biochem. Pharmacol. 14:483–488.

    Article  PubMed  CAS  Google Scholar 

  • Garattini, S., Caccia, S., Mennini, T., Samanin, R., Consolo, S., and Ladinsky, H. (1979). Biochemical pharmacology of the anorectic drug fenfluramine: a review.Curr. Med. Res. Opin. 6(suppl 1): 15–27.

    CAS  Google Scholar 

  • Hjorth, S., and Sharp, T. (1993).In vivo microdialysis evidence for central serotonin 1 A and serotonin 1B autoreceptor blocking properties of the beta adrenoceptor antagonist (-)penbutolol.J. Pharmacol. Exp. Ther. 265:707–712.

    PubMed  CAS  Google Scholar 

  • Kuhn, D.M., Wolf, W.A., and Youdim, M.B.H. (1985). 5-Hydroxytryptamine releasein vivo from a cytoplasmic pool: studies on the 5-HT behavioural syndrome in reserpinized rats.Br. J. Pharmacol. 84:121–129.

    PubMed  CAS  Google Scholar 

  • Lee, S. H., and Fisher, B. (1961). Portacaval shunt in the rat.Surgery 50:668–672.

    PubMed  CAS  Google Scholar 

  • Mans, A.M., DeJoseph, M.R., Davis, D.W., Vina, J.R., and Hawkins, R.A. (1990). Early establishment of cerebral dysfunction after portacaval shunting.Am. J. Physiol. 259:E104-E110.

    PubMed  CAS  Google Scholar 

  • Mousseau, D.D., and Butterworth, R.F. (1994). Current theories on the pathogenesis of hepatic encephalopathy.Exp. Biol. Med. 206:329–344.

    CAS  Google Scholar 

  • Schröder, R., Müller, O., and Bircher, J. (1985). The portacaval and splenocaval shunt in the normal rat. A morphometric and functional reevaluation.J. Hepatol. 1:107–123.

    Article  PubMed  Google Scholar 

  • Swain, M.S., Blei, A.T., Butterworth, R.F., and Kraig, R.P. (1991). Intracellular pH rises and astrocytes swell after portacaval anastomosis in rats.Regulatory Intergrative Comp. Physiol. 30:R1491-R1496

    Google Scholar 

  • Trulson, M.E., and Jacobs, B.L. (1976). Behavioral evidence for the rapid release of CNS serotonin by PCA and fenfluramine.Eur. J. Pharmacol. 36:149–154.

    Article  PubMed  CAS  Google Scholar 

  • Wichems, C.H., Hollingsworth, C.K., and Bennett, B.A. (1995). Release of serotonin induced by 3,4-methylenedioxymethamphetamine (MDMA) and other substituted amphetamines in cultured fetal raphe neurons: further evidence for calcium-independent mechanisms of release.Brain Res 695:10–18.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Peter B. F. Bergqvist.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bergqvist, P.B.F., Hjorth, S., Wikell, C. et al. p-chloroamphetamine- and d-fenfluramine-induced brain serotonin release in experimental portal-systemic encephalopathy. Metab Brain Dis 12, 229–236 (1997). https://doi.org/10.1007/BF02674615

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02674615

Keywords

Navigation